Histopathological analyses of AD model mice reveal extensive glial activation, demonstrated by intense immunohistochemical labeling of Iba-1-positive microglia and GFAP-expressing astrocytes throughout affected brain regions (Figure 4e). This evidence concerns the gene GFAP and Alzheimer disease.